Yuguero Oriol, Guzman Marianela, Castañ Teresa, Forné Carles, Galindo Gisela, Pujol Jesus
Institut de Recerca Biomèdica de Lleida (IRBLLEIDA), Lleida, España.
Servei d'Atenció Primària, Regió Sanitària de Lleida, Lleida, España.
Neurocirugia (Astur : Engl Ed). 2018 Sep-Oct;29(5):233-239. doi: 10.1016/j.neucir.2018.05.001. Epub 2018 Jun 10.
To determine mortality and complications of patients with traumatic brain injury (TBI) with antiplatelet or anticoagulant treatment in a hospital emergency department.
Study of hospital cohorts of the 243 patients who attended with pure TBI to the emergency service of the Arnau de Vilanova University Hospital in Lleida between June 1, 2015 and June 1, 2016. Sociodemographic, clinical and other variables related to clinical management were collected. Presence of complications and in-hospital mortality were registered at 24hours, at 48hours and one week after TBI.
Overall, 50.2% of patients were men, with median age of 80.8years, and without CT-scan findings at admission in 62.3% of cases. A total of 14 patients died (5.8%). Overall mortality was associated with comorbidity, with knowledge loss and with fluctuation of the Glasgow comma scale in the acute process. Patients treated with anticoagulants (39.5%) or antiplatelet agents (33.3%) were older, with higher degree of dependency and more comorbidity, but did not present more complications. Without reaching statistical significance, higher mortality was observed during the first week in anticoagulated patients (7.3% vs 4.8%, P=.585) or with antiplatelet treatment (8.6% vs 4.3%, P=.241) with respect to those not treated.
No worse results have been observed in number of complications in patients with TBI treated with anticoagulant or antiplatelet treatment, so clinical management seems appropriate. The higher mortality could be explained by the greater complexity of these patients. It would be necessary to carry out more studies, preferably prospective with follow-up after discharge, in order to establish causal mechanisms between clinical management and mortality or associated complications to TBI.
确定在医院急诊科接受抗血小板或抗凝治疗的创伤性脑损伤(TBI)患者的死亡率和并发症情况。
对2015年6月1日至2016年6月1日期间前往莱里达的阿尔瑙·德·维拉诺瓦大学医院急诊科就诊的243例单纯TBI患者的医院队列进行研究。收集社会人口统计学、临床及其他与临床管理相关的变量。记录TBI后24小时、48小时和1周时的并发症情况及院内死亡率。
总体而言,50.2%的患者为男性,中位年龄为80.8岁,62.3%的病例入院时CT扫描无异常发现。共有14例患者死亡(5.8%)。总体死亡率与合并症、意识丧失及急性病程中格拉斯哥昏迷量表的波动有关。接受抗凝治疗(39.5%)或抗血小板药物治疗(33.3%)的患者年龄较大,依赖程度较高且合并症较多,但并发症并未更多。与未接受治疗的患者相比,抗凝患者(7.3%对4.8%,P = 0.585)或接受抗血小板治疗的患者(8.6%对4.3%,P = 0.241)在第一周的死亡率较高,但未达到统计学意义。
接受抗凝或抗血小板治疗的TBI患者并发症数量未见更差结果,因此临床管理似乎是合适的。较高的死亡率可能由这些患者更复杂的病情所解释。有必要开展更多研究,最好是前瞻性研究并在出院后进行随访,以确定临床管理与死亡率或TBI相关并发症之间的因果机制。